|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2600122226 |
|
最近更新日期: Date of Last Refreshed on: |
2026-04-10 11:05:08 |
|
注册时间: Date of Registration: |
2026-04-10 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
基于炎性复合指标的老年非小细胞肺癌患者术前衰弱风险评估模型的构建与验证 |
|
Public title: |
Construction and validation of a preoperative frailty risk assessment model for elderly non-small cell lung cancer patients based on inflammatory composite indicators |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于炎性复合指标的老年非小细胞肺癌患者术前衰弱风险评估模型的构建与验证 |
|
Scientific title: |
Construction and validation of a preoperative frailty risk assessment model for elderly non-small cell lung cancer patients based on inflammatory composite indicators |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
王文娇 |
研究负责人: |
王文娇 |
|
Applicant: |
Wang Wenjiao |
Study leader: |
Wang Wenjiao |
|
申请注册联系人电话: Applicant telephone: |
+86 138 1074 8910 |
研究负责人电话:
Study leader's |
+86 138 1074 8910 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
jiaoaodeying@126.com |
研究负责人电子邮件: Study leader's E-mail: |
jiaoaodeying@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市朝阳区工体南路8号 |
研究负责人通讯地址: |
北京市朝阳区工体南路8号 |
|
Applicant address: |
No. 8, Gongti South Road, Chaoyang District, Beijing |
Study leader's address: |
No. 8, Gongti South Road, Chaoyang District, Beijing |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
首都医科大学附属北京朝阳医院 |
||
|
Applicant's institution: |
Beijing Chaoyang Hospital, Affiliated to Capital Medical University |
||
|
研究负责人所在单位: |
首都医科大学附属北京朝阳医院 |
||
|
Affiliation of the Leader: |
Beijing Chaoyang Hospital, Affiliated to Capital Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2026-科-397 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
首都医科大学附属北京朝阳医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Beijing Chaoyang Hospital, Capital Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2026-03-25 00:00:00 | ||
|
伦理委员会联系人: |
吕亚丽 |
||
|
Contact Name of the ethic committee: |
Lv Lali |
||
|
伦理委员会联系地址: |
北京市朝阳区工体南路8号 |
||
|
Contact Address of the ethic committee: |
No. 8, Gongti South Road, Chaoyang District, Beijing |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 85231484 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
首都医科大学附属北京朝阳医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Beijing Chaoyang Hospital, Affiliated to Capital Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市朝阳区工体南路8号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 8, Gongti South Road, Chaoyang District, Beijing |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
院级课题经费 |
||||||||||||||||||||||
|
Source(s) of funding: |
College-level project funding |
||||||||||||||||||||||
|
研究疾病: |
非小细胞肺癌 |
||||||||||||||||||||||
|
Target disease: |
Non-small cell lung cancer |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
(1)分析老年非小细胞肺癌患者术前衰弱现状及其影响因素。 (2)基于炎性复合指标构建老年非小细胞肺癌患者术前衰弱风险评估模型,并验证该模型的应用效果。 |
||||||||||||||||||||||
|
Objectives of Study: |
(1) Analyze the preoperative frailty status and its influencing factors in elderly patients with non-small cell lung cancer. (2) Construct a preoperative frailty risk assessment model for elderly patients with non-small cell lung cancer based on inflammatory composite indicators, and verify the application effect of this model. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
①符合《中华医学会肺癌临床诊疗指南(2025版)》中非小细胞肺癌的诊断标准;②年龄≥60岁; ③手术指征明确; ④意识清楚,具有一定阅读和作答能力,自愿参与本研究并签署知情同意书。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Meet the diagnostic criteria for non-small cell lung cancer in the "Clinical Practice Guidelines for Lung Cancer of the Chinese Medical Association (2025 Edition)"; 2. Age ≥ 60 years; 3. Clear surgical indications; 4. Conscious, with certain reading and answering abilities, voluntarily participating in this study and signing the informed consent form. |
||||||||||||||||||||||
|
排除标准: |
①患有精神疾病或意识障碍的患者;②合并有急性感染、血液系统疾病、自身免疫性疾病、其他活动性恶性肿瘤;③肝、肾功能衰竭者;④术前进行放化疗者;⑤因疾病卧床、瘫痪等原因而无法下地行走者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Patients with mental illness or consciousness disorders; 2. Those with acute infections, hematologic diseases, autoimmune diseases, or other active malignant tumors; 3. Patients with liver or kidney failure; 4. Those who undergo radiotherapy or chemotherapy before surgery; 5. Patients who cannot walk due to being bedridden, paralysis, or other reasons. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-03-01 00:00:00至 To 2026-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2026-04-15 00:00:00 至 To 2026-10-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
不共享 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Do not share |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
本研究通过文献回顾和咨询专家,初步筛选老年非小细胞肺癌患者术前衰弱的危险因素,然后设计相关因素调查表,内容包括一般资料、临床资料和评估表。正式调查前对3名研究调查员进行统一培训,严格按照纳入和排除标准筛选调查对象,取得其知情同意后收集相关资料。本研究对问卷收集者设盲,由 1 名研究人员收集患者衰弱评估的相关资料,其他研究人员收集剩余资料后交由第3人录入数据。资料调查表在按要求完成数据录入和核查后,按编号的顺序归档保存。电子数据文件应分类保存,并有多个备份保存于不同磁盘或记录介质上,妥善保存,防止损坏。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
This study preliminarily screened the risk factors for preoperative frailty in elderly patients with non-small cell lung cancer through a literature review and consultations with experts. A related factors survey questionnaire was then designed, including general information, clinical data, and assessment forms. Before the formal survey, three research investigators received unified training, and survey subjects were strictly screened according to the inclusion and exclusion criteria. Relevant information was collected after obtaining their informed consent. This study employed a blinded approach for questionnaire collectors: one researcher collected data related to the patients' frailty assessments, while other researchers collected the remaining information and handed it over to a third person for data entry. After data entry and verification were completed as required, the information forms were archived and stored in numerical order. Electronic data files should be saved in categorized formats, with multiple backups stored on different disks or recording media, properly preserved to prevent damage. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |